Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2008-03-27 |
| Study Made Public: | 2012-04-04 |
Title
Weiss_Sattentau-ZM96-gp140
Description
CAVD 291 is an antibody production study using ZM96 gp140 as an immunogen to raise neutralizing monoclonal antibodies in humanized Ig mice.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.